These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7000904)

  • 1. Suppression of the line-10 guinea pig hepatocarcinoma by antigens related to both Mycobacterium bovis (BCG) and the tumor.
    Minden P; Mathews HL; Kelleher PJ
    J Immunol; 1980 Dec; 125(6):2685-9. PubMed ID: 7000904
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of growth of guinea pig line-10 hepatocarcinoma. II. Effect of passive transfer of xenogeneic and syngeneic antibodies and normal lymphoid cells.
    Minden P; Brunda MJ; Ferguson HR
    J Immunol; 1978 Nov; 121(5):1933-8. PubMed ID: 712072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of growth of guinea pig line-10 hepatocarcinoma. I. Effect of simultaneous administration of tumor cells and antibodies from normal rabbits.
    Brunda MJ; Minden P; Heusser CH; Ferguson HR
    J Immunol; 1978 Mar; 120(3):831-6. PubMed ID: 75927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to bacterial and tumor-derived antigens in sera from normal guinea pigs.
    Brunda MJ; Minden P
    J Immunol; 1977 Oct; 119(4):1374-7. PubMed ID: 197169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Purification, characterization and immunological study of 2 protein antigens of the BCG strain Mycobacterium bovis].
    De Bruyn J; Turneer M
    Bull Mem Acad R Med Belg; 1988; 143(1-2):157-70. PubMed ID: 3052672
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppression and immunotherapy of the guinea pig line 10 hepatocarcinoma mediated by heat-killed disrupted Mycobacterium bovis strain Bacillus Calmette-Guérin.
    Minden P; Mathews HL
    Cancer Res; 1980 Sep; 40(9):3214-7. PubMed ID: 6159072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief communication: antigenic relationship between Mycobacterium bovis (BCG) and a guinea pig hepatoma.
    Borsos T; Rapp HJ
    J Natl Cancer Inst; 1973 Sep; 51(3):1085-6. PubMed ID: 4355214
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on diagnostic potential of secretory antigens of Mycobacterium bovis.
    Trivedi S; Das SK; Kumar R; Chandra R
    Indian J Exp Biol; 2006 Jan; 44(1):14-8. PubMed ID: 16430085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

  • 10. Suppression and immunotherapy of the guinea pig line-10 hepatocarcinoma mediated by nonviable Staphylococcus aureus.
    Minden P; McClatchy JK; Brunda MJ
    J Natl Cancer Inst; 1978 Aug; 61(2):535-8. PubMed ID: 210295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1972 Dec; 35():345-58. PubMed ID: 4349152
    [No Abstract]   [Full Text] [Related]  

  • 12. A 64 kDa protein from Mycobacterium bovis BCG shares the same antigenic determinants with line 10 hepatoma cells and has anti-line 10 tumor activity.
    Ahsan CR; Sasaki J
    FEBS Lett; 1991 Aug; 288(1-2):77-80. PubMed ID: 1715293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells.
    Minden P; McClatchy JK; Wainberg M; Weiss DW
    J Natl Cancer Inst; 1974 Nov; 53(5):1325-31. PubMed ID: 4139280
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of murine tumor growth by immune reaction to the Bacillus Calmette-Guérin strain of Mycobacterium bovis.
    Bartlett GL; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1972 Jan; 48(1):245-57. PubMed ID: 4568964
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on the specificity and antigenic composition of fractions from Mycobacterium tuberculosis, bovine type and Mycobacterium fortuitum. 3. Hemagglutination, hemolysis and complement fixation reactions].
    Micke H
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Aug; 131(2):134-69. PubMed ID: 4231175
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunogenicity of Mycobacterium tuberculosis antigens in Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle.
    Mustafa AS; Skeiky YA; Al-Attiyah R; Alderson MR; Hewinson RG; Vordermeier HM
    Infect Immun; 2006 Aug; 74(8):4566-72. PubMed ID: 16861643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of isoniazid on BCG-mediated tumor immunity.
    Romolo JL; Loyd B; Cohen MH
    Surg Forum; 1977; 28():158-9. PubMed ID: 364713
    [No Abstract]   [Full Text] [Related]  

  • 18. Synergistic activity of components of mycobacteria and mutant Salmonella in causing regression of line-10 tumors in guinea pigs.
    McLaughlin CA; Hargrave SL; Bickel WD; Ribi E
    Cancer Res; 1979 May; 39(5):1766-71. PubMed ID: 371795
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor suppression by cell walls of mycobacterium bovis attached to oil droplets.
    Zbar B; Rapp HJ; Ribi EE
    J Natl Cancer Inst; 1972 Mar; 48(3):831-5. PubMed ID: 4333775
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunotherapy of the guinea pig line 10 hepatocarcinoma with a variety of nonviable bacteria.
    Brunda MJ; Mathews HL; Ferguson HR; McClatchy JK; Minden P
    Cancer Res; 1980 Sep; 40(9):3211-3. PubMed ID: 6775802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.